Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Randomized,double-blind,multicenter,multinational,parallel-group,Phase III study to
demonstrate the superiority of the triple fixed combination of
Beclometasone+Formoterol+Glycopyrrolate (BDP/FF/GB) administered via pMDI over the equivalent
dose of Foster® in COPD (Chronic Obstructive Pulmonary Disease) patients after 52 weeks of
treatment